AstraZeneca PLC LSE:AZN:
ASTRAZENECA PLC - DATROWAY RECOMMENDED FOR APPROVAL IN EU FOR TNBC
ASTRAZENECA - CHMP RECOMMENDS DATROWAY FOR APPROVAL IN EU AS 1ST-LINE TREATMENT FOR METASTATIC TNBC
Reuters
AstraZeneca Says CHMP Recommends Datroway For Approval In EU As 1st-Line Treatment For Metastatic TNBC
- Sources
- Reuters
- Markets
- Stocks
- Active symbols
- LSE:AZN
- Language
- English
AstraZeneca PLC LSE:AZN: